-3x Short ARK (SARKK) | Stock Overview & Key Data

-3x Short ARK Innovation ETP | Small-cap

€0.05

-21.69%

| -3x Short ARK Stock Comparison:

-3x Short ARK vs Renewi Plc -3x Short ARK vs Ferrari Group PLC -3x Short ARK vs Wereldhave N.V -3x Short ARK vs LS 3X Long -3x Short ARK vs Pharming Group N.V -3x Short ARK vs AEX Index | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

-3x Short ARK Performance Comparison

Loading chart data...

-3x Short ARK

AEX Index

View Full Price History

Stock Range

Today's Range

Low: €0.05 High: €0.05

on June 17, 2025

52 Week Range

Low: €0.05 High: €0.89

on June 16, 2025

on August 5, 2024

All-Time High: €12.10 on March 30, 2015

Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights

Key Statistics

Market Cap i €12.5M

EPS i 0.03

P/E Ratio (TTM) i 1.94

Forward P/E i N/A

P/B Ratio i 0.01

PEG Ratio i -0.02

Div. Yield i 34.42%

ROE i 1.11%

Beta i N/A

Debt to Equity i 0.03

Financial Highlights

Profitability

Gross Margin i 28.04%

Operating Margin i N/A

Profit Margin i 14.91%

Returns and Earnings

Return on Assets (TTM) i 0.82%

Return on Equity (TTM) i 1.11%

EBITDA i €267.5M

Net Income (TTM) i €7.0M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
-3x Short ARK SARKK	12.53M Small-cap	0.00%	-37.50%	-76.19%	-64.29%	-73.68%	-90.16%	-99.17%	-99.43%
Renewi Plc RWI	830.45M Mid-cap	0.39%	1.58%	1.38%	5.53%	6.30%	31.71%	23.95%	244.48%
Ferrari Group PLC FERGR	821.70M Mid-cap	1.00%	12.41%	13.53%	0.67%	0.67%	1.24%	1.24%	1.24%
Wereldhave N.V WHA	799.22M Mid-cap	-0.80%	7.78%	11.78%	27.45%	24.01%	30.54%	22.30%	104.69%
LS 3X Long 3CON	674.59M Mid-cap	-1.53%	-7.69%	59.75%	-83.83%	-67.26%	-92.34%	-93.87%	-93.96%
Pharming Group N.V PHARM	661.36M Mid-cap	-4.85%	15.29%	20.99%	15.29%	2.08%	31.08%	40.58%	-22.40%

Ownership & Short Interest

Insider Ownership i N/A

Institutional Ownership i N/A

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 54K

Average 90-Day Volume i 34K

-3x Short ARK Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in -3x Short ARK would have performed over time.

Investment Amount

€

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is SARKK's 52-week high and low?

In the last 52 weeks, -3x Short ARK reached a high of €0.89 (on August 5, 2024) and a low of €0.05 (on June 16, 2025).

What is the market cap and P/E ratio for SARKK?

Curious about -3x Short ARK's size and valuation? Its market capitalization stands at 12.53M. When it comes to valuation, the P/E ratio (trailing twelve months) is 1.94, and the forward P/E (looking ahead) is N/A.

Does SARKK pay dividends? If so, what's the yield?

Yes, -3x Short ARK is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 34.42%, and the company is expected to pay out €0.08 per share over the coming year.

Who are -3x Short ARK's main competitors or similar companies to consider before investing?

When looking at -3x Short ARK, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Renewi Plc RWI	830.45M	Industrials	Waste Management	31.71%	23.95%
Ferrari Group PLC FERGR	821.70M	N/A	N/A	1.24%	1.24%
Wereldhave N.V WHA	799.22M	Real Estate	Real Estate - Development	30.54%	22.30%
LS 3X Long 3CON	674.59M	N/A	N/A	-92.34%	-93.87%
Pharming Group N.V PHARM	661.36M	Healthcare	Biotechnology	31.08%	40.58%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for -3x Short ARK Innovation ETP? (e.g., ROE, Debt/Equity)

To get a sense of -3x Short ARK's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.11%, the Debt to Equity ratio from the most recent quarter is 0.03, and its Gross Profit Margin stands at 28.04%.

What is the recent revenue and earnings growth for SARKK?

Looking at -3x Short ARK's growth, its revenue over the trailing twelve months (TTM) was €865M. Compared to the same quarter last year (YoY), quarterly revenue grew by 22.39%, and quarterly earnings saw a YoY growth of 103.99%.

How much of SARKK stock is held by insiders and institutions?

Wondering who owns -3x Short ARK stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.